Synthesis and Characterization of Novel 2-Acyl-3-trifluoromethylquinoxaline 1,4-Dioxides as Potential Antimicrobial Agents
Authors:
- Galina I. BuravchenkoGBGalina I. Buravchenko
- Dmitry A. MaslovDMDmitry A. Maslov
- Shah AlamSAShah Alam
- Natalia E. GrammatikovaNGNatalia E. Grammatikova
- Svetlana G. FrolovaSFSvetlana G. Frolova
- Aleksey A. VatlinAVAleksey A. Vatlin
- Xirong TianXTXirong Tian
- Ivan V. IvanovIIIvan V. Ivanov
- Olga B. BekkerOBOlga B. Bekker
- Maxim A. KryakvinMKMaxim A. Kryakvin
- Olga A. DontsovaODOlga A. Dontsova
- Valery N. DanilenkoVDValery N. Danilenko
Open Access
- 27 January 2022
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (2) , 155
Abstract
The emergence of drug resistance in pathogens leads to a loss of effectiveness of antimicrobials and complicates the treatment of bacterial infections. Quinoxaline 1,4-dioxides represent a prospective scaffold for search of new compounds with improved chemotherapeutic characteristics. Novel 2-acyl-3-trifluoromethylquinoxaline 1,4-dioxides with alteration of substituents at position 2 and 6 were synthesized via nucleophilic substitution with piperazine moiety and evaluated against a broad panel of bacteria and fungi by measuring their minimal inhibitory concentrations. Their mode of action was assessed by whole-genomic sequencing of spontaneous drug-resistant Mycobacterium smegmatis mutants, followed by comparative genomic analysis, and on an original pDualrep2 system. Most of the 2-acyl-3-trifluoromethylquinoxaline 1,4-dioxides showed high antibacterial properties against Gram-positive strains, including mycobacteria, and the introduction of a halogen atom in the position 6 of the quinoxaline ring further increased their activity, with 13c being the most active compound. The mode of action studies confirmed the DNA-damaging nature of the obtained quinoxaline 1,4-dioxides, while drug-resistance may be provided by mutations in redox homeostasis genes, encoding enzymes potentially involved in the activation of the compounds. This study extends views about the antimicrobial and antifungal activities of the quinoxaline 1,4-dioxides and can potentially lead to the discovery of new antibacterial drugs.Keywords
Funding Information
- Russian Science Foundation (21-45-00018, 21-64-00006)
- National Natural Science Foundation of China (82061138019)
- the National Key R&D Program of China (2021YFA1300904)
This publication has 59 references indexed in Scilit:
- Cyclic Voltammetric Study of Some Anti‐Chagas‐Active 1,4‐Dioxidoquinoxalin‐2‐yl Ketone DerivativesHelvetica Chimica Acta, 2013
- Primer-BLAST: A tool to design target-specific primers for polymerase chain reactionBMC Bioinformatics, 2012
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingGenome Research, 2012
- A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing dataBioinformatics, 2011
- 3-Trifluoromethylquinoxaline N,N′-Dioxides as Anti-Trypanosomatid Agents. Identification of Optimal Anti-T. cruzi Agents and Mechanism of Action StudiesJournal of Medicinal Chemistry, 2011
- Fast and accurate long-read alignment with Burrows–Wheeler transformBioinformatics, 2010
- 5(6)-Fluoro-6(5)-R-benzofuroxans: synthesis and NMR , and studiesJournal of Fluorine Chemistry, 2004
- Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxidesEuropean Journal of Medicinal Chemistry, 2004
- 13C NMR of polycyclic aromatic compounds. A reviewMagnetic Resonance in Chemistry, 1979
- Contribution to the Chemistry of Benzfuroxan and Benzfurazan DerivativesJournal of the American Chemical Society, 1954